<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C26EC5DC-44D6-4728-8540-416E1CC7A2CB"><gtr:id>C26EC5DC-44D6-4728-8540-416E1CC7A2CB</gtr:id><gtr:name>University of Lisbon</gtr:name><gtr:address><gtr:line1>Campo Grande</gtr:line1><gtr:line2>Edificio C5</gtr:line2><gtr:line3>1749-016</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1A7923D7-9B3D-4944-8DC6-0C9F65AC96A4"><gtr:id>1A7923D7-9B3D-4944-8DC6-0C9F65AC96A4</gtr:id><gtr:name>La Jolla Pharmaceutical Company</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Clinical Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C26EC5DC-44D6-4728-8540-416E1CC7A2CB"><gtr:id>C26EC5DC-44D6-4728-8540-416E1CC7A2CB</gtr:id><gtr:name>University of Lisbon</gtr:name><gtr:address><gtr:line1>Campo Grande</gtr:line1><gtr:line2>Edificio C5</gtr:line2><gtr:line3>1749-016</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1A7923D7-9B3D-4944-8DC6-0C9F65AC96A4"><gtr:id>1A7923D7-9B3D-4944-8DC6-0C9F65AC96A4</gtr:id><gtr:name>La Jolla Pharmaceutical Company</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/10560645-34E8-4617-A3C3-4C40175F363E"><gtr:id>10560645-34E8-4617-A3C3-4C40175F363E</gtr:id><gtr:firstName>Hal</gtr:firstName><gtr:surname>Drakesmith</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B2F3B3ED-8B79-4562-89E6-7C8324D2F35B"><gtr:id>B2F3B3ED-8B79-4562-89E6-7C8324D2F35B</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Newbold</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0901149"><gtr:id>F8CA4740-0386-4152-AC37-D63489E10089</gtr:id><gtr:title>Iron metabolism and malarial pathogenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901149</gtr:grantReference><gtr:abstractText>It is estimated two fifths of the world?s population is at risk from malaria. Malaria is a disease caused by infection with the parasite Plasmodium. The parasite has a complicated life-cycle, and lives in cells in the liver, and in red blood cells. Although several treatments to combat malaria exist, we still need to know more about how the parasite lives in humans in order to effectively control the disease. Plasmodium needs iron to survive, and obtains its iron from its human host. Investigating how this happens, and how iron influences the growth and life-cycle of the parasite, are the aims of this project. A better understanding of these issues may allow regulation of iron transport to inhibit Plasmodium, and benefit infected humans.</gtr:abstractText><gtr:technicalSummary>Malaria, caused by infections of the protozoan parasite Plasmodium, causes significant morbidity and mortality, particularly in the developing world. In 2006 the results of a clinical trial involving iron supplementation to infants in Tanzania revealed an increased incidence of malaria-related events. The life-cycle of Plasmodium includes a liver-stage and an erythrocyte stage. The liver controls host iron homeostasis by making hepcidin, and most iron in the body resides within red cells. There are likely to be crucial links between Plasmodium biology and host iron transport, and the Tanzania trial re-emphasized this. The mechanisms by which iron metabolism and Plasmodium interact are important for at least two reasons; iron availability controls the growth the pathogen, and anaemia associated with malaria is a major cause of disease. However the molecular interactions between iron transport and Plasmodium are poorly understood.
In this grant application we address this issue in two ways. First we will examine the effect of the liver- and the red-cell stages of infection on synthesis of the peptide hormone hepcidin. Hepcidin is the master regulator of host iron homeostasis, and reduces iron supply to the erythron by inhibiting dietary iron absorption and iron recycling by macrophages. Changes in hepatocyte hepcidin levels during liver infection would influence the erythrocyte population that are the targets for next stage of Plasmodium infection. For the red cell stage, we have found that hepcidin mRNA expression is stimulated by parasitized erythrocytes in vitro. High hepcidin levels cause anaemia, so exploring the basis of Plasmodium-induced hepcidin may allow a better understanding of malarial anaemia and suggest new interventions. The molecular mechanisms controlling hepcidin synthesis are quite well understood, but how malaria affects these pathways has not been explored. Our second line of work will investigate the effects of iron availability on Plasmodium growth and commitment to gametocytogenesis. Using recently developed methods we will test whether adding iron to parasite cultures promotes Plasmodium asexual replication. These experiments have some specific value in the context of the results of the Tanzania trial mentioned above. Instead of dividing asexually, Plasmodium can decide to commit to making gametocytes, the form that is transmittable from human to mosquito. Because gametocyte levels correlate with anaemia, we propose that reduced intraerythrocytic iron levels provoke gametocytogenesis. We describe experiments aimed at testing this hypothesis.</gtr:technicalSummary><gtr:fund><gtr:end>2013-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>459784</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>interview in which the work of my lab is described</gtr:description><gtr:id>2561D17F-EE5B-49CB-95A5-439D6B06F070</gtr:id><gtr:impact>students and post-docs joking my lab have said they viewed the podcast and this did not discourage them too much...</gtr:impact><gtr:outcomeId>56d586e751f342.35983455</gtr:outcomeId><gtr:title>Podcast describing my research</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>http://www.ndm.ox.ac.uk/hal-drakesmith-iron-and-infection</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Lisbon</gtr:collaboratingOrganisation><gtr:country>Portugal, Portuguese Republic</gtr:country><gtr:department>Institute for Molecular Medicine</gtr:department><gtr:description>Malaria and hepcidin</gtr:description><gtr:id>9423F509-7CEC-4703-BD93-1539D2ACF07E</gtr:id><gtr:impact>Host-mediated regulation of superinfection in malaria.
Portugal S, Carret C, Recker M, Armitage AE, Gon&amp;ccedil;alves LA, Epiphanio S, Sullivan D, Roy C, Newbold CI, Drakesmith H, Mota MM.
Nat Med. 2011 Jun;17(6):732-7. Epub 2011 May 15.</gtr:impact><gtr:outcomeId>JUg69kpcw1t-1</gtr:outcomeId><gtr:partnerContribution>co-work on a publication</gtr:partnerContribution><gtr:piContribution>role of hepcidin in malarial pathogenesis especially superinfection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>La Jolla Pharmaceutical Company</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Do hepcidin and haem enhance the anti-malarial efficacy of artemsinin?</gtr:description><gtr:id>0F5C0486-8631-4090-9B6C-D35DF89FF448</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>58c7ce7a552c44.67868189-1</gtr:outcomeId><gtr:partnerContribution>funding and reagents</gtr:partnerContribution><gtr:piContribution>We are testing whether hepcidin and haem enhance the anti-malarial efficacy of artemsinin</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>bbc web page</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>737AEEE3-9DF0-4082-AE98-D032C0122870</gtr:id><gtr:impact>A press release on the paper that has been generated from this research published in Nature Medicine was arranged through the MRC Press Office, and the BBC ran a news item on the work.
http://www.bbc.co.uk/news/health-13387983


added interest from scientific colleagues not working in malaria.</gtr:impact><gtr:outcomeId>HFZJQtxYd54</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/health-13387983</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (London)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B68A5803-E0B1-4F9C-A9C7-97D082065B2E</gtr:id><gtr:impact>A talk on malaria and infectious diseases to a school in London.


I was invited back to judge at the School's science fair.</gtr:impact><gtr:outcomeId>PhZUZjKx917</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>La Jolla Pharmaceutical Company research grant</gtr:description><gtr:fundingOrg>La Jolla Pharmaceutical Company</gtr:fundingOrg><gtr:id>5059E456-741F-40E7-A668-A36DBED3B5E8</gtr:id><gtr:outcomeId>58c7d15ba48f84.24149385</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Oxford Biomedical Research Centre</gtr:department><gtr:description>BRC Start-up</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Oxford University Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>BBE7430D-41DF-4385-B99C-235A638E5342</gtr:id><gtr:outcomeId>Cq5AWNiB9R1</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Gates Foundation Global Health Grant</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:fundingRef>OPP1055865</gtr:fundingRef><gtr:id>FD4D7416-19CA-4731-B090-7934433BC410</gtr:id><gtr:outcomeId>Uwa8uGtmP2C</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>we have modified and optimised a commercially available Elisa kit to measure hepcidin, the master regulator of iron metabolism, in human serum / plasma</gtr:description><gtr:id>86C98FDD-9F27-4598-9990-B27FCDE458E2</gtr:id><gtr:impact>Blood. 2012 Feb 23;119(8):1922-8. Epub 2012 Jan 6.
Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children.
Prentice AM, Doherty CP, Abrams SA, Cox SE, Atkinson SH, Verhoef H, Armitage AE, Drakesmith H.
and other publications Atkinson et al Blood 2014; Pasricha et al Sci Transl Med 2014; Armitage et al PNAS 2014

Gates Foundation Global Health Grant to study use of hepcidin to guide iron supplementation</gtr:impact><gtr:outcomeId>g87NSp838MM</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>serum hepcidin measurement</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>FEEF4384-DFBB-4788-A2CA-792CD435F03F</gtr:id><gtr:title>Iron Deficiency Anemia: Problems in Diagnosis and Prevention at the Population Level.</gtr:title><gtr:parentPublicationTitle>Hematology/oncology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/393f975ed0d279c1e271776d221d70b0"><gtr:id>393f975ed0d279c1e271776d221d70b0</gtr:id><gtr:otherNames>Pasricha SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0889-8588</gtr:issn><gtr:outcomeId>58c5b3bca80b83.08878408</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A70DF6D-0AEA-4CCE-9377-7EBE33008C08</gtr:id><gtr:title>Implications of malaria on iron deficiency control strategies.</gtr:title><gtr:parentPublicationTitle>Advances in nutrition (Bethesda, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f74b171beed8655598b3801c6e65ac4"><gtr:id>8f74b171beed8655598b3801c6e65ac4</gtr:id><gtr:otherNames>Spottiswoode N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2161-8313</gtr:issn><gtr:outcomeId>pm_14899_29_22797994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5432A0A-F881-4E12-9DD2-9CE5D88E9376</gtr:id><gtr:title>Hepcidin and the iron-infection axis.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69897495557bb9049b1db1d20db3e201"><gtr:id>69897495557bb9049b1db1d20db3e201</gtr:id><gtr:otherNames>Drakesmith H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_14899_29_23139325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A9A5519-CE53-4C3B-832E-02C0B2665506</gtr:id><gtr:title>Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31264a957b5f94441cb867314a82e27f"><gtr:id>31264a957b5f94441cb867314a82e27f</gtr:id><gtr:otherNames>Prentice AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_14899_29_22228627</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CA75CF9-E66D-42A2-92E2-FF02F4E294E6</gtr:id><gtr:title>Cord Blood Hepcidin: Cross-Sectional Correlates and Associations with Anemia, Malaria, and Mortality in a Tanzanian Birth Cohort Study.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40fce04c808ecba0ff3bb14f2715b780"><gtr:id>40fce04c808ecba0ff3bb14f2715b780</gtr:id><gtr:otherNames>Brickley EB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn><gtr:outcomeId>58c5b3bc343ad3.40821650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0385687-5610-418C-BE57-5AB89E519FD0</gtr:id><gtr:title>From one Nobel Prize (P. Ehrlich) to another (Tu Youyou): 100 years of chemotherapy of infectious diseases.</gtr:title><gtr:parentPublicationTitle>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c21a1d6fad09c59ccbad113d3cba79c"><gtr:id>1c21a1d6fad09c59ccbad113d3cba79c</gtr:id><gtr:otherNames>Cabantchik ZI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1198-743X</gtr:issn><gtr:outcomeId>56d571b23042f8.10451148</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43A83B46-E2E7-4E02-82E2-71CF6F3045FC</gtr:id><gtr:title>Control of iron deficiency anemia in low- and middle-income countries.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/393f975ed0d279c1e271776d221d70b0"><gtr:id>393f975ed0d279c1e271776d221d70b0</gtr:id><gtr:otherNames>Pasricha SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_14899_29_23355536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>653EB9BC-34E8-4BDF-B968-637489F85CC3</gtr:id><gtr:title>Host-mediated regulation of superinfection in malaria.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb2ed4312d1b152da48896bb0c932747"><gtr:id>fb2ed4312d1b152da48896bb0c932747</gtr:id><gtr:otherNames>Portugal S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>p4cYxgimS9a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>378A441D-EA67-4789-BD0B-06C640A090D1</gtr:id><gtr:title>Iron, anemia and hepcidin in malaria.</gtr:title><gtr:parentPublicationTitle>Frontiers in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f74b171beed8655598b3801c6e65ac4"><gtr:id>8f74b171beed8655598b3801c6e65ac4</gtr:id><gtr:otherNames>Spottiswoode N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1663-9812</gtr:issn><gtr:outcomeId>5458e0cc2e8424.10160888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44F74418-EDB1-46CF-8B1D-E6A0EA505328</gtr:id><gtr:title>Expression of the iron hormone hepcidin distinguishes different types of anemia in African children.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/393f975ed0d279c1e271776d221d70b0"><gtr:id>393f975ed0d279c1e271776d221d70b0</gtr:id><gtr:otherNames>Pasricha SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>doi_14899_ed_3008249</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CF61786-139E-405D-81E8-276D684BEA80</gtr:id><gtr:title>Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc5d54fd557c51a327ad1d34b5322226"><gtr:id>bc5d54fd557c51a327ad1d34b5322226</gtr:id><gtr:otherNames>Atkinson SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>doi_14899__10_533000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51DE1D71-20E7-49F6-AF88-7BCC47732A97</gtr:id><gtr:title>Hepcidin regulation by innate immune and infectious stimuli.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13c9270163e5a00e5919e9e956c231ab"><gtr:id>13c9270163e5a00e5919e9e956c231ab</gtr:id><gtr:otherNames>Armitage AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>Vx73nG2khgC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B47E0F8-9EB0-41CB-B123-52EA8334321E</gtr:id><gtr:title>Role of Activins in Hepcidin Regulation during Malaria.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f74b171beed8655598b3801c6e65ac4"><gtr:id>8f74b171beed8655598b3801c6e65ac4</gtr:id><gtr:otherNames>Spottiswoode N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>5aa7940f04c680.32218242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF29F232-33D1-43FE-82C5-FCBDB707CEA6</gtr:id><gtr:title>Malaria and Age Variably but Critically Control Hepcidin Throughout Childhood in Kenya.</gtr:title><gtr:parentPublicationTitle>EBioMedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc5d54fd557c51a327ad1d34b5322226"><gtr:id>bc5d54fd557c51a327ad1d34b5322226</gtr:id><gtr:otherNames>Atkinson SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2352-3964</gtr:issn><gtr:outcomeId>56d571b2557fd1.34240932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9D80ACC-2833-4F07-8B94-43E12EB905D8</gtr:id><gtr:title>Regulation of Hepcidin by Erythropoiesis: The Story So Far.</gtr:title><gtr:parentPublicationTitle>Annual review of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/393f975ed0d279c1e271776d221d70b0"><gtr:id>393f975ed0d279c1e271776d221d70b0</gtr:id><gtr:otherNames>Pasricha SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0199-9885</gtr:issn><gtr:outcomeId>58c5b3bc887a13.83939913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C3674D4-045D-4616-AE2F-F77CE319066F</gtr:id><gtr:title>Hepcidin in malaria superinfection: can findings be translated to humans?</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/613b6e881d662b026f699556a4fe77c8"><gtr:id>613b6e881d662b026f699556a4fe77c8</gtr:id><gtr:otherNames>van Santen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>gVEjgX9jNsU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B658F58-A1CE-4657-A94D-D7475D9C30AF</gtr:id><gtr:title>Superinfection in malaria: Plasmodium shows its iron will.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb2ed4312d1b152da48896bb0c932747"><gtr:id>fb2ed4312d1b152da48896bb0c932747</gtr:id><gtr:otherNames>Portugal S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>hhe7K3f9XzG</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901149</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>